id: F7A4N8
gene_symbol: CTDSP2
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:9796
  label: Equus caballus
description: >-
  F7A4N8 is a 174-residue product predicted from one alternative transcript
  (ENSECAT00000020049) of the horse CTDSP2 gene (ENSECAG00000018788, chromosome 6),
  which encodes the small CTD phosphatase SCP2. Its first 84 residues are essentially
  identical to the N-terminal non-catalytic region of human CTDSP2, after which the
  transcript uses an extended exon whose extra sequence encodes 90 unrelated residues
  and a stop codon. The product therefore lacks the entire FCP1-homology (HAD-type)
  phosphatase domain, including the DxDx(T/V) motif that carries the nucleophilic and
  proton-donor aspartates. Other transcripts of the same gene (Ensembl canonical
  ENSECAT00000107019, UniProt A0A9L0T5X1, 312 aa; and ENSECAT00000138494, A0A9L0R207,
  252 aa) do encode the complete catalytic domain, and the full-length product groups
  with CTDSP2 orthologs (PANTHER PTHR12210:SF187 members in human, mouse and cow)
  rather than with CTDSP1 or CTDSPL. In mammals the full-length enzyme is a nuclear
  Mg2+-dependent phosphatase that preferentially removes phosphate from Ser5 of the RNA
  polymerase II CTD and is recruited by REST to silence RE-1-containing neuronal genes
  in non-neuronal cells. Because the truncated F7A4N8 product lacks the catalytic domain
  and its transcript carries a premature stop codon upstream of four exon junctions, it
  has no demonstrable enzymatic function, and it may be a nonsense-mediated-decay
  transcript or annotation artefact rather than a stable protein.
existing_annotations: []
suggested_questions:
- question: Is ENSECAT00000020049, the transcript encoding F7A4N8, supported by horse RNA-seq
    or long-read data? Its 375-bp exon extends 273 nt upstream of the canonical 102-bp exon
    acceptor and introduces a premature stop codon upstream of four further exon junctions,
    the signature of a nonsense-mediated-decay or intron-retention isoform rather than a
    stable protein product.
  experts: []
- question: Which horse CTDSP2 model best represents the real full-length product? The Ensembl
    canonical model (A0A9L0T5X1, 312 aa) has an N-terminal extension that does not begin with
    methionine and omits the 13-residue SDLLQCLQYQFYQ exon present in human CTDSP2, whereas
    A0A9L0R207 (252 aa) keeps that exon but omits the 19-residue exon that forms part of the
    catalytic fold. Neither model reproduces the human 271-residue architecture exactly.
  experts: []
- question: If a short F7A4N8-like protein is made, does its retained N-terminal segment (which
    in the SCP proteins lies outside the catalytic domain) have any function, such as competing
    with full-length CTDSP2 for partners, or is it simply degraded?
  experts: []
suggested_experiments:
- hypothesis: The F7A4N8-encoding transcript (ENSECAT00000020049) is a minor, NMD-targeted
    isoform, and the dominant horse CTDSP2 transcript encodes a full-length catalytic protein
    like human CTDSP2.
  description: Quantify junction-spanning reads for the extended exon versus the canonical
    102-bp exon acceptor in public horse RNA-seq (e.g. FAANG tissues), and compare isoform
    abundance in horse cells with and without NMD inhibition (cycloheximide or UPF1
    knockdown). Confirm full-length ORFs by long-read (Iso-Seq) sequencing.
  experiment_type: transcript isoform quantification / NMD sensitivity
- hypothesis: Phosphatase activity on RNA polymerase II CTD Ser5 is carried by the full-length
    horse CTDSP2 product and is absent from F7A4N8, which lacks the catalytic domain.
  description: Express the full-length horse CTDSP2 product and F7A4N8, and assay phosphate
    release from a Ser5-phosphorylated CTD heptapeptide substrate, with human CTDSP2 as a
    positive control and a catalytic-aspartate (D-to-A) mutant as a negative control.
  experiment_type: in vitro phosphatase assay with Ser5-phosphorylated CTD substrate
references:
- id: file:HORSE/CTDSP2/CTDSP2-uniprot.txt
  title: 'UniProtKB F7A4N8: selected horse CTDSP2 protein model'
  findings:
  - statement: F7A4N8 is an unreviewed (PE 4, predicted) 174-residue TrEMBL record imported
      from an Ensembl gene model, with no equine experimental characterization.
    record_section: [PE]
    supporting_text: 'PE   4: Predicted;'
    reference_section_type: DATABASE_ENTRY
  - statement: The record maps to Ensembl transcript ENSECAT00000020049 of gene ENSECAG00000018788
      and to the VGNC CTDSP2 locus; the gene symbol identifies the locus, not this transcript's
      function.
    record_section: ["DR:Ensembl"]
    supporting_text: 'DR   Ensembl; ENSECAT00000020049.4; ENSECAP00000016443.3; ENSECAG00000018788.4.'
    reference_section_type: DATABASE_ENTRY
  - statement: The only sequence features predicted on the record are a disordered, low-complexity
      stretch inside the transcript-specific C-terminal tail; no phosphatase domain signature
      is matched.
    record_section: ["FT:REGION"]
    supporting_text: /note="Disordered"
    reference_section_type: DATABASE_ENTRY
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Source record for the reviewed product. Naming is computational (Ensembl model
      plus VGNC symbol); it fixes the locus identity but establishes no function for this
      transcript product. The re-review replaced a former finding that quoted the GN line,
      which restates a label.
- id: file:HORSE/CTDSP2/CTDSP2-bioinformatics/RESULTS.md
  title: CTDSP2 human-horse sequence comparison
  findings:
  - statement: A forced global alignment of F7A4N8 against human CTDSP2 pairs 170 residues;
      the re-review analysis shows the identity is concentrated in the first 84 residues and
      the rest of the pairing is alignment noise against an unrelated tail.
    supporting_text: Paired coverage is 62.7% of human O14595 (271 aa) and 97.7% of horse
      F7A4N8 (174 aa).
    reference_section_type: RESULTS
  - statement: The alignment is not a reciprocal orthology test and does not by itself license
      transferring the human catalytic annotation to this product.
    supporting_text: This measures conservation between the identified records. It is not a
      reciprocal orthology analysis and does not itself validate a functional annotation.
    reference_section_type: RESULTS
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Earlier reproducible Biopython global alignment. Its feature table correctly
      records that both human catalytic aspartates are unaligned in F7A4N8. The 57.1% identity
      over 170 paired residues overstates similarity beyond residue 84, because a global alignment
      with these gap penalties pairs the unrelated C-terminal tail. Superseded for gene-model
      and placement questions by RESULTS-rereview.md.
- id: file:HORSE/CTDSP2/CTDSP2-bioinformatics/RESULTS-rereview.md
  title: CTDSP2 (horse) re-review gene model and phylogenetic placement
  findings:
  - statement: The horse CTDSP2 gene has three Ensembl protein-coding transcripts. F7A4N8 comes
      from the non-canonical ENSECAT00000020049, whose sixth exon (375 bp) extends 273 nt upstream
      of the 102-bp exon used by both other transcripts.
    supporting_text: 76298535-76298161 (375 bp)
    reference_section_type: RESULTS
  - statement: F7A4N8 shares only an 84-residue prefix with human CTDSP2 and lacks the DxDx(T/V)
      catalytic motif found at human position 107.
    supporting_text: '| horse_CTDSP2gene_F7A4N8 | 174 | 84 | 109/164 | none |'
    reference_section_type: RESULTS
  - statement: The Ensembl canonical horse product A0A9L0T5X1 (312 aa) retains the catalytic
      DLDET motif at position 148.
    supporting_text: "| horse_CTDSP2gene_A0A9L0T5X1 | 312 | 0 | 248/258 | [(148, 'DLDET')] |"
    reference_section_type: RESULTS
  - statement: Over the catalytic region, the full-length horse product is 99.4% identical to
      human CTDSP2 and groups with CTDSP2 orthologs, well separated from CTDSP1 (78%) and CTDSPL
      (81%).
    supporting_text: '| human_CTDSP2_O14595 | 0.994 |'
    reference_section_type: RESULTS
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Re-review analysis (compare_sequences_rereview.py), computed from cached UniProt
      sequences and the Ensembl REST gene model, with no hand-entered values. The comparators human,
      mouse and cow CTDSP2 are all PANTHER PTHR12210:SF187 members in the PANTHER 19.0 classification
      files; horse is not a PANTHER reference proteome, so its placement rests on this tree plus
      the VGNC orthology assignment.
- id: file:human/CTDSP2/CTDSP2-uniprot.txt
  title: 'UniProtKB O14595: human CTDSP2 catalytic features'
  findings:
  - statement: Human CTDSP2 is a small CTD phosphatase that preferentially dephosphorylates
      Ser-5 of the POLR2A C-terminal heptapeptide repeats and negatively regulates RNA polymerase
      II transcription.
    record_section: ["CC:FUNCTION"]
    supporting_text: "FUNCTION: Preferentially catalyzes the dephosphorylation of 'Ser-5'"
    reference_section_type: DATABASE_ENTRY
  - statement: Human CTDSP2 is recruited by REST to RE-1-element neuronal genes, silencing
      them in non-neuronal cells.
    record_section: ["CC:FUNCTION"]
    supporting_text: by REST to neuronal genes that contain RE-1 elements, leading to
    reference_section_type: DATABASE_ENTRY
  - statement: The catalytic machinery sits in the FCP1-homology domain spanning human residues
      97-255, outside the 84-residue N-terminal segment that F7A4N8 shares with human CTDSP2.
    record_section: ["FT:DOMAIN"]
    supporting_text: DOMAIN          97..255
    reference_section_type: DATABASE_ENTRY
  - statement: Catalysis requires the aspartate pair Asp107 (4-aspartylphosphate intermediate)
      and Asp109 (proton donor), neither of which has a counterpart in F7A4N8.
    record_section: ["FT:ACT_SITE"]
    supporting_text: ACT_SITE        107
    reference_section_type: DATABASE_ENTRY
  - statement: Human CTDSP2 is nuclear, though by similarity rather than by direct experiment.
    record_section: ["CC:SUBCELLULAR LOCATION"]
    supporting_text: 'SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.'
    reference_section_type: DATABASE_ENTRY
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Curated Swiss-Prot record for the human ortholog (same PANTHER subfamily SF187
      as the full-length horse product). It describes the characterized biology and gives the
      residue coordinates that show this truncated product lacks the catalytic domain.
- id: PMID:12721286
  title: A novel RNA polymerase II C-terminal domain phosphatase that preferentially dephosphorylates
    serine 5.
  full_text_unavailable: true
  findings:
  - statement: The small CTD phosphatase (SCP) family, of which CTDSP2 is a member, preferentially
      dephosphorylates Ser5 within the RNA polymerase II CTD consensus repeat.
    supporting_text: This study describes a family of small CTD phosphatases (SCPs) that preferentially
      catalyze the dephosphorylation of Ser5 within the consensus repeat.
    reference_section_type: ABSTRACT
  - statement: The SCPs repress transcription through their phosphatase activity. Expressing SCP1
      inhibits activated transcription, whereas a phosphatase-inactive mutant enhances it, so the
      repressor role cannot be transferred to a product that lacks the active site.
    supporting_text: Expression of SCP1 inhibits activated transcription from a number of promoters,
      whereas a phosphatase-inactive mutant of SCP1 enhances transcription.
    reference_section_type: ABSTRACT
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: One of the two primary sources behind the human CTDSP2 FUNCTION annotation.
      Abstract-only in the local cache, and the abstract foregrounds SCP1; it cannot establish
      by itself which assays were performed on CTDSP2/SCP2. Cited for family biology, not as
      equine evidence.
- id: PMID:15681389
  title: Small CTD phosphatases function in silencing neuronal gene expression.
  full_text_unavailable: true
  findings:
  - statement: REST/NRSF recruits the SCP family (SCP1 to SCP3, including CTDSP2) to RE-1-element
      neuronal genes to silence them in non-neuronal cells.
    supporting_text: We show that REST/NRSF recruits SCPs to neuronal genes that contain RE-1
      elements, leading to neuronal gene silencing in non-neuronal cells.
    reference_section_type: ABSTRACT
  - statement: SCP-mediated neuronal gene silencing is conserved as far as Drosophila, consistent
      with the full-length horse CTDSP2 product retaining the conserved catalytic domain.
    supporting_text: Thus, SCP activity is an evolutionarily conserved transcriptional regulator
      that acts globally to silence neuronal genes.
    reference_section_type: ABSTRACT
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: The REST/neuronal-silencing source behind the curated human record. Abstract-only
      in the local cache; it addresses the SCP family (SCPs 1 to 3) rather than CTDSP2 in isolation.
      Cited for pathway context, not as equine evidence.
